Less Ads, More Data, More Tools Register for FREE

Pin to quick picksActiveops Regulatory News (AOM)

Share Price Information for Activeops (AOM)

Share Price is delayed by 15 minutes
Get Live Data
259.50    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 9.00 (3.529%)
Market Cap: £185.42m
AOM Live PriceLast checked at - London Stock Exchange

Intraday Activeops Share Chart

Board Changes

25 Jul 2024 07:00

RNS Number : 7364X
ActiveOps PLC
25 July 2024
 

25 July 2024 

 

ActiveOps plc 

("ActiveOps", the "Company" or the "Group") 

 

Board Changes

 

ActiveOps plc (AIM: AOM), a leading provider of Decision Intelligence software for service operations, today announces changes to the composition of its Board of Directors ("Board").

 

As announced on 5 December 2023, after 10 years on the Board, Sean Finnan will not be standing for re-election as Chair at the Company's forthcoming AGM, expected to be held on 26 September 2024. At that time, it is intended that Richard Jeffery, CEO and co-founder of ActiveOps, will transition to the role of Executive Chairman, leading the Board and maintaining leadership responsibility for the Finance and Risk functions of the Group. Also at that time, Hilary Wright, independent Non-Executive Director and Chair of the Remuneration Committee will assume the role of Senior Independent Director, while Mike McLaren will remain as an Independent Non-Executive Director and Chair of the Audit Committee.

 

To ensure an appropriate balance of independent directors and increase the Company's depth of US expertise, ActiveOps is pleased to announce the appointment of Bruce R Lee to the Board as an Independent Non-Executive Director with effect from 1 September 2024. Bruce brings strong technical leadership expertise from his career as a corporate CIO and deep familiarity with ActiveOps' target customers in US financial services and healthcare. His previous roles included senior leadership positions at the New York Stock Exchange, BNP Paribas, HSBC, Fannie Mae and Centene Healthcare. Bruce will chair the Nominations Committee and, reflecting this expertise and experience, will also chair a new Board committee responsible for the Group proposition and technologies.

 

ActiveOps Chair, Sean Finnan commented: "It has been both a privilege and a pleasure to serve as ActiveOps' Chairman. I have great pride in how the Group has successfully established itself as a public company, consistently delivering on its commitments made at IPO. I feel extremely positive that this new Board structure has the expertise and responsibilities to guide the firm through its next stage of growth. I wish to thank my Board and company colleagues and the shareholders past and present for their ongoing support of our success."

 

ActiveOps CEO, Richard Jeffery added: "On behalf of ActiveOps' Board of Directors and all the staff, I would like to thank Sean for his contributions to the Group. ActiveOps was a very different company when Sean first joined and over the past 10 years he has been central to its success. As a non-executive Director and subsequently Chair, Sean has been an invaluable adviser to me and my team and we wish him all the very best. I am honoured to be taking on this role in September and excited to be welcoming Bruce to the Board, providing us with knowledge, experience and insight as we look to drive our growth rate and capitalise on the growing demand for AI-powered solutions to support service operations."

Additional information

 

The following information is being disclosed pursuant to Rule 17 and paragraph (g) of Schedule 2 of the AIM Rules for Companies in relation to the appointed of Bruce R Lee to the Board.

 

Bruce Roger Lee, aged 59, has been a director or partner of the following companies or partnerships during the five years preceding the date of this announcement:

 

Current directorships:

Past directorships (last five years)

LeeBRAdvisory LLC

None

 

Save as set out above there are no further disclosures required pursuant to Rule 17 or Schedule Two, paragraph (g) of the AIM Rules for Companies.

 

For more information, please contact:

 

ActiveOps

Via Alma

Richard Jeffery, Chief Executive Officer

www.activeops.com

Emma Salthouse, Chief Financial Officer

 

Investec Bank plc

+44 (0)20 7597 5970

Corporate Broking & PLC Advisory

Patrick Robb / Nick Prowting

 

Alma Strategic Communications

+ 44(0) 203 405 0205

Caroline Forde / Will Ellis Hancock

 

About ActiveOps

 

ActiveOps is Software as a Service business, dedicated to helping organisations create MORE value from their service operations. ActiveOps' Decision Intelligence software solutions are specifically designed to support leaders with the vast number of decisions they make daily in the name of running their operations. Our customers make better decisions and consume less time and effort making them. The outcomes are significantly improved turnaround times and double-digit improvements in productivity with backlogs of work materially reduced. Customers also leverage the capacity created to invest in transformation and development, as well as to reduce levels of new recruitment.

 

The Company's AI-powered SaaS solutions are underpinned by 15+ years of operational data and its AOM methodology which is proven to drive cross department decision-making. 

 

The Company has over 180 employees, serving a global customer base of enterprise customers from offices in the UK, Ireland, USA, Canada, Australia, India, and South Africa. The Group's customers are predominantly in the banking, insurance, healthcare administration and business process outsourcing (BPO) sectors, including Nationwide, TD Bank, Elevance and DXC Technology.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOABIGDRCBDDGSS
Date   Source Headline
20th Feb 202412:02 pmRNSDirector/PDMR Dealing
20th Feb 20247:15 amRNSHolding(s) in Company
30th Jan 202410:49 amRNSDirector/PDMR Dealing
19th Jan 20241:00 pmRNSDirector/PDMR Dealing
28th Dec 20233:32 pmRNSDirector/PDMR Dealing
19th Dec 202312:12 pmRNSDirector/PDMR Dealing
7th Dec 20237:00 amRNSHolding(s) in Company
5th Dec 20237:00 amRNSBoard Succession Planning
27th Nov 20234:20 pmRNSDirector/PDMR Dealing
21st Nov 20233:55 pmRNSDirector/PDMR Dealing
14th Nov 20237:00 amRNSInterim Results
10th Nov 20237:00 amRNSNotice of Investor Presentation
8th Nov 20234:29 pmRNSDirector/PDMR Dealing
18th Oct 20234:59 pmRNSDirector/PDMR Dealing
18th Oct 20237:00 amRNSTrading Update and Notice of Half Year Results
28th Sep 202312:48 pmRNSResult of AGM
26th Sep 202311:52 amRNSDirector/PDMR Dealing
26th Sep 20237:00 amRNSLaunch of ControliQ Series 3
18th Sep 20233:01 pmRNSDirector/PDMR Dealing
5th Sep 20237:00 amRNSAppointment of Chief Financial Officer
24th Aug 20232:31 pmRNSDirector/PDMR Dealing
23rd Aug 20235:58 pmRNSPublication of Annual Report and Notice of AGM
18th Aug 20234:59 pmRNSDirector/PDMR Dealing
27th Jul 20231:54 pmRNSHolding(s) in Company
26th Jul 20232:16 pmRNSHolding(s) in Company
25th Jul 20237:00 amRNSDirector/PDMR Dealing
18th Jul 20233:46 pmRNSDirector/PDMR Dealing
4th Jul 20237:00 amRNSResults for the year ended 31 March 2023
28th Jun 20234:36 pmRNSDirector/PDMR Dealing
26th Jun 20237:00 amRNSNotice of Results and Investor Presentation
19th Jun 20233:13 pmRNSDirector/PDMR Dealing
25th May 202311:20 amRNSDirector/PDMR Dealing
19th May 20231:14 pmRNSDirector/PDMR Dealing
25th Apr 20237:00 amRNSFull Year Trading Update
24th Apr 20234:41 pmRNSDirector/PDMR Dealing
21st Apr 202311:45 amRNSDirector/PDMR Shareholding
28th Mar 20237:00 amRNSAppointment of new Chief Financial Officer
27th Mar 20231:14 pmRNSDirector/PDMR Dealing
21st Mar 20237:00 amRNSDirector/PDMR Dealing
27th Feb 20237:00 amRNSDirector/PDMR Dealing
20th Feb 202310:38 amRNSDirector/PDMR Dealing
24th Jan 20231:27 pmRNSDirector/PDMR Dealing
18th Jan 202311:18 amRNSDirector/PDMR Dealing
29th Dec 202212:48 pmRNSDirector/PDMR Shareholding
20th Dec 20227:00 amRNSDirector/PDMR Shareholding
16th Dec 20227:00 amRNSDirectorate Change
7th Dec 20225:38 pmRNSHolding(s) in Company
1st Dec 202212:01 pmRNSHolding(s) in Company
29th Nov 20227:00 amRNSInterim Results
25th Nov 202210:12 amRNSDirector/PDMR Dealing

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.